Spots Global Cancer Trial Database for Perception of Cure Among Patients With Metastatic Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Perception of Cure Among Patients With Metastatic Cancer

Official Title: The Perception of Cure Among Patients With Metastatic Cancer

Study ID: NCT04820894

Conditions

Hematopoietic and Lymphoid Cell Neoplasm

Metastatic Malignant Solid Neoplasm

Interventions

Electronic Medical Record

Survey Administration

Study Description

Brief Summary: This study collects information about perception of cure among patients with cancer that has spread to other places in the body (metastatic). This study aims to determine patients' perception (knowledge) before starting immunotherapy and if differences exist in understanding of treatment to stimulate or restore the ability of the body's immune (defense) system to fight infection and disease (immunotherapy) based on social and economic factors or on race/ethnicity.

Detailed Description: PRIMARY OBJECTIVE: I. To assess the proportion of patients with metastatic cancer who anticipate cure before starting immunotherapy. SECONDARY OBJECTIVES: I. To determine if expectations of cure are associated with quality of life and distress. II. To determine if patients' perceptions differ by gender, age, and ethnicity. OUTLINE: Patients complete surveys over 30 minutes about sociodemographic information and perception of immunotherapy, over 10 minutes about expectations of cure, over 10 minutes about anxiety, over 10 minutes about depression, and over 30 minutes about physical well-being. Patients' medical records are reviewed.